Bone marrow cytokeratin 19 mRNA level is an independent predictor of relapse-free survival in operable breast cancer patients

被引：0
|
作者：
Ragne K. Farmen
Oddmund Nordgård
Bjørnar Gilje
Fuad V. Shammas
Jan T. Kvaløy
Satu Oltedal
Reino Heikkilä
机构：
[1] Stavanger University Hospital,Department of Hematology and Oncology
[2] University of Stavanger,Department of Mathematics and Natural Science
[3] Stavanger University Hospital,Division of Research and Human Resources
[4] Gena AS,undefined
来源：
Breast Cancer Research and Treatment | 2008年 / 108卷
关键词：
Breast cancer; Bone marrow; Micrometastases; Real-time RT-PCR; Cytokeratin 19; Recurrence;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：251 / 258
页数：7
相关论文
共 50 条
  • [31] Factors associated with relapse-free survival after neoadjuvant chemotherapy for breast cancer
    Thomae, Keith
    Sargent
    Russell, Christy A.
    Russell
    AMERICAN JOURNAL OF SURGERY, 2022, 223 (03): : 543 - 543
  • [32] Polygenic risk score and relapse-free survival in bladder cancer patients
    Buerger, H.
    Golka, K.
    Blaszkewicz, M.
    Hengstler, J. G.
    Selinski, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S86 - S86
  • [33] Biologically active cancer cells in the bone marrow of breast cancer patients secrete cytokeratin-19
    Alix-Panabieres, C.
    Vendrell, J.
    Pelle, O.
    Riethdorf, S.
    Mueller, V.
    Fabbro, M.
    Pantel, K.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 12 - 12
  • [34] Clinical and pathological factors related to brain relapse-free survival in breast cancer patients-reply
    Li, Rong
    Zhang, Kui
    Siegal, Gene P.
    HUMAN PATHOLOGY, 2017, 69 : 142 - 142
  • [35] Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: Year of treatment an independent predictor of outcome
    Kupelian, PA
    Buchsbaum, JC
    Elshaikh, MA
    Reddy, CA
    Klein, EA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (03): : 629 - 634
  • [36] PREDICTION OF EARLY RELAPSE IN PATIENTS WITH OPERABLE BREAST-CANCER BY DETECTION OF OCCULT BONE-MARROW MICROMETASTASES
    COTE, RJ
    ROSEN, PP
    LESSER, ML
    OLD, LJ
    OSBORNE, MP
    JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (10) : 1749 - 1756
  • [37] Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
    Emmanouil Saloustros
    Maria Perraki
    Stella Apostolaki
    Galatea Kallergi
    Alexandros Xyrafas
    Kostas Kalbakis
    Sophia Agelaki
    Antonia Kalykaki
    Vassilis Georgoulias
    Dimitris Mavroudis
    Breast Cancer Research, 13
  • [38] Cytokeratin-19 mRNA-positive circulating tumor cells during follow-up of patients with operable breast cancer: prognostic relevance for late relapse
    Saloustros, Emmanouil
    Perraki, Maria
    Apostolaki, Stella
    Kallergi, Galatea
    Xyrafas, Alexandros
    Kalbakis, Kostas
    Agelaki, Sophia
    Kalykaki, Antonia
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    BREAST CANCER RESEARCH, 2011, 13 (03)
  • [39] Preoperative EUS-FNA as a predictor of relapse-free and overall survival in patients with esophageal carcinoma
    Vazquez-Sequeiros, E
    Levy, MJ
    Clain, JE
    Schwartz, DA
    Jondal, ML
    Wiersema, MJ
    GASTROINTESTINAL ENDOSCOPY, 2002, 55 (05) : AB183 - AB183
  • [40] Perioperative assessment of the kinetics of circulating tumour cells in patients with operable breast cancer based on cytokeratin-19 mRNA detection
    Daskalakis, M.
    Askoxylakis, I.
    Mavroudis, D.
    Sanidas, E.
    Georgoulias, V.
    Mlissas, J.
    Tsiftsis, D. D.
    EJC SUPPLEMENTS, 2010, 8 (03): : 107 - 107
12345